Thyroid hormone and cardiovascular diseases

doi:10.3969/j.issn.1004-583X.2016.03.005

Abstract

CLC Number:

R581

Zhao Zhansheng. Thyroid hormone and cardiovascular diseases[J]. Clinical Focus, 2016, 31(3): 250-253.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2016.03.005

https://huicui.hebmu.edu.cn/EN/Y2016/V31/I3/250

[1] Lin JZ, Sieglaff DH, Yuan C, et al. Gene specific actions of thyroid hormone receptor subtypes[J].PLoS One, 2013, 8(1):e52407.
[2] Vargas-Uricoechea H, Bonelo-Perdom A, Sierra-Torres CH. Effects of thyroid hormones on the heart[J]. Clin Invest Arterioscl, 2014,26(6):296-309.
[3] Mitchell JE, Hellkamp AS,Mark DB, et al. Thyroid function in heart failure and impact on mortality[J]. JACC Heart Fail, 2013,1(1): 48- 55.
[4] Grais IM, Sowers JR.Thyroid and the heart[J].Am J Med, 2014,127(8):691-698.
[5] Chan PH, Hai J, Yeung CY, et al. Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation[J]. Clin Cardiol, 2015, 38(8):476-582.
[6] Narayana SK, Woods DR, Boos CJ.Management of amiodarone-related thyroid problems[J].Ther Adv Endocrinol Metab, 2011,2(3):115-126.
[7] 张佳,李红.　甲状腺功能亢进症合并肺动脉高压临床分析[J].中华内分泌代谢杂志, 2014, 30(2): 133-134.
[8] Sugiura T, Yamanaka S, Takeuchi H, et al.Autoimmunity and pulmonary hypertension in patients with Graves' disease[J].Heart Vessels, 2015, 30(5):642-646.
[9] Bahn RS, Burch HB, Cooper DS, et al. American Thyroid Association; American Association of clinical endocrinologists. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists[J].Endocr Pract,2011,17(3):456-520.
[10] Rodondi N, Bauer DC. Subclinical hypothyroidism and cardiovascular risk: how to end the controversy[J]. JCEM,2013, 98(6):2267-2269.
[11] Collet TH, Gussekloo J, Bauer DC,et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality[J]. Arch Intern Med, 2012, 172(10):799-809.
[12] van Tienhoven-Wind LJ, Dullaart RP. Low-normal thyroid function and novel cardiometabolic biomarkers [J]. Nutrients, 2015, 7(2):1352-1377.
[13] Yeap BB, Alfonso H, Hankey GJ,et al. Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study[J]. Eur J Endocrinol, 2013,169(4):401-408.
[14] Palmeiro C, Davila MI, Bhat M, et al. Subclinical hyperthyroidism and cardiovascular risk: recommendations for treatment[J].Cardiol Rev, 2013,21(6):300-308.

[1]	Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi. Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis [J]. Clinical Focus, 2022, 37(9): 773-778.
[2]	Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng. Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm [J]. Clinical Focus, 2022, 37(5): 406-411.
[3]	Zhang Lei, Lou Haidong, Zhi Yu, Qi Shuying. Efficacy and safety of PCSK9 inhibitors on atherosclerotic cardiovascular disease: A meta-analysis [J]. Clinical Focus, 2022, 37(12): 1074-1080.
[4]	Cai Kexin, Guo Hongju, Yu Shuxia, Chang Lirong. Effect of levothyroxine for pregnancy outcomes due to subclinical hypothyroidism during pregnancy: A meta-analysis [J]. Clinical Focus, 2021, 36(9): 773-777.
[5]	Geng Yanping, Wang Lili, Gu Jian, Qi Peng, Chen Shuxia. Validity and reliability analysis of Chinese version of AntiClot Treatment Scale [J]. Clinical Focus, 2020, 35(9): 788-791.
[6]	Nian Shiyana, Feng Leib. Difference of cardiovascular biochemical indicators among Dai, Hani and Yi in Yuanjiang county of Yunnan Province [J]. Clinical Focus, 2020, 35(8): 689-692.
[7]	Zhang Lingxia, Nie Qian, Hao Zhihua, Liu Chenghao, Wang Zhongli, Chen Feifei, Liu Huanxin. Effects of indoor and outdoor working environment on inflammatory markers of cardiovascular system [J]. Clinical Focus, 2020, 35(3): 224-227.
[8]	Nuozha Dainier, Muhuyati. Metaanalysis of factors influencing recurrence after radiofrequency ablation of atrial fibrillation [J]. Clinical Focus, 2019, 34(3): 267-272.
[9]	Li Yi, Yao Mahui, Liu Demin, Wang Qian, Geng Xue, Cui Wei. Prognostic value of pulse wave velocity and anklebrachial index [J]. Clinical Focus, 2019, 34(11): 986-990.
[10]	Li Liang Wang Mei. Research progress on antiplatelet therapy in special populations of acute coronary syndrome [J]. Clinical Focus, 2018, 33(9): 767-770.
[11]	Rao Mingyue, Wang Yaling, Zhang Guoru, Wang Mei. Advances in anticoagulant therapy after acute coronary syndrome [J]. Clinical Focus, 2018, 33(9): 761-766.
[12]	Niu Guochao, Yin Fengrong, Zhang Xiaolan. Clinical features and treatment of statinsinduced liver injury [J]. Clinical Focus, 2018, 33(6): 478-481.
[13]	Zhao Jia1, Li Gang2. Indications for statins in primary prevention of cardiovascular disease [J]. Clinical Focus, 2018, 33(6): 465-468.
[14]	Liang Yi1, Hu Rui2，3. The blood lipids and its clinical significance [J]. Clinical Focus, 2018, 33(6): 461-464.
[15]	Liu Shasha1， Chen Dan2， Zhang Jing1， Huang Yuting1， Alimila·Saiyitijiang1， Nai Zhihui1， Gao Ying1. Complement C3 level and relationship with apolipoprotein B in essential hypertension patients [J]. Clinical Focus, 2017, 32(9): 752-754,758.

Thyroid hormone and cardiovascular diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments